For generations, medical students were taught that the map of the human body was essentially complete. Yet cancer imaging has ...

Men such as Tony Webber have limited, and expensive, treatment options for advanced prostate cancer. A new program aims to ...

– 32nd Annual Scientific Retreat brought together 600+ prostate cancer researchers and leaders to spotlight breakthrough discoveries and advance cutting-edge science – – PCF continues to be the ...

PSA and Ki-67 tumour markers may identify high-risk metastatic castration-sensitive prostate cancer and inform treatment ...

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. Researchers at the Norwegian ...

For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its ...

City of Hope ® , one of the largest and most advanced cancer research and treatment organizations in the United States with ...

North East patients are among the first in the UK to trial Lutetium (177Lu) rhPSMA-10.1, a new targeted treatment for advanced prostate cancer resistant to hormone therapy.

What key experiences or clinical gaps motivated your focus on advancing prostate cancer diagnostics, particularly MRI-led ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

On World Cancer Day 2026, oncologists spoke about the early signs of prostate cancer, which are often mistaken for ...